Wikidata

(Q64150112)

English

Phase 4 Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis

clinical trial

In more languages

Statements

short name
EARNEST (English)
0 references
title
A Randomized, Double-Blind, Placebo-Controlled Phase 4 Study to Evaluate the Efficacy and Safety of Entyvio (Vedolizumab IV) in the Treatment of Chronic Pouchitis (EARNEST) (English)
0 references
country
Belgium
0 references
Canada
0 references
France
0 references
Germany
0 references
Italy
0 references
Netherlands
0 references
Spain
0 references
United Kingdom
0 references
start time
12 October 2016
0 references
end time
6 November 2019
0 references
number of participants
110
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q64150112&oldid=1857568558"